You are here
- Home
- Therapy Areas
- Oncology/Infection
A methodology study to support the future investigation of AZD2171 in patients with Acute Myeloid Leukaemia (AML)
- Disease
- colorectal cancer
- Drug Name
- RECENTIN
- Generic Name
- AZD2171
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Mar 22, 2004
- Study Name
- D8480M00001
- Study Id
- D8480M00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
